Immunovant

Immunovant, Inc. is a clinical-stage immunology company focused on developing innovative treatments for autoimmune diseases. The company's mission is to enable normal lives for individuals living with these complex and unpredictable conditions. Immunovant is a trailblazer in anti-FcRn technology, utilizing this approach to create targeted therapies that reduce harmful IgG autoantibodies, a common factor in autoimmune diseases.

Their investigational therapies, IMVT-1402 and Batoclimab, are designed to address a variety of IgG-mediated autoimmune diseases. Immunovant is committed to patient-focused innovation and actively engages with patients and advocates to inform their research and development efforts. The company believes that by listening to and learning from individuals affected by autoimmune diseases, they can create therapies that better meet their specific needs.

Immunovant offers a variety of flexible work options for its employees, including remote work and unlimited paid time off. This allows employees to manage their work-life balance and have flexibility in their schedules. The company also offers a generous parental leave policy, with 12 weeks of paid leave, further demonstrating their commitment to supporting employees in all stages of life.

Immunovant offers a comprehensive benefits package designed to support employee well-being and professional growth. These benefits include unlimited paid time off, generous parental leave, a 401(k) plan with a company match, an equity incentive plan, opportunities for career development and remote work options, and comprehensive health and wellness benefits. The company also provides flexible spending accounts and commuter benefits.

Immunovant is a clinical-stage immunology company dedicated to developing innovative, targeted therapies to address the complex and variable needs of people with autoimmune diseases. They are committed to enabling normal lives for people living with these conditions through their pioneering work in anti-FcRn technology.

Immunovant fosters a culture of innovation, collaboration, and compassion. They encourage creative thinking and a sense of urgency to accelerate the development of treatments for autoimmune diseases. Their inclusive and diverse workforce values equity and belonging, empowering employees to bring their best selves to work.

Immunovant champions an environment of inclusivity and equity by inviting all voices of their employees, promoting a creative and collaborative workplace that leads to genuine connection and innovation. They are committed to diversity across race, gender, age, religion, physical ability, identity, sexual orientation, and experience, and as they expand their reach throughout the biotechnology ecosystem, they establish relationships with external partners who also value diversity and inclusivity. Immunovant believes that celebrating diversity empowers all employees to be their best authentic selves.